Microsoft and Meta Surge; Eli Lilly Slides; Harley Davidson and Tariffs

Stock Movers

Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

5d ago 4:05

MP3•Episode home

On this episode of Stock Movers:
- Microsoft (MSFT) shares are higher this morning after an earnings blowout. The company reported stronger-than-expected quarterly sales and profit growth as the Azure cloud unit posted a 33% revenue gain in the quarter, beating the Wall Street estimate of 29%. It suggests customer demand for cloud services has held steady despite a wave of tariffs and economic turbulence. The world’s largest software maker is considered a leader in commercializing AI products, thanks to its close partnership with ChatGPT maker OpenAI. In addition to providing computing infrastructure, Microsoft has launched AI assistants in widely used productivity applications such as Office and Excel.
- Meta (META) shares, along with Microsoft, are helping lead the Mag 7 higher after the company reported $42.3 billion in first-quarter sales, beating analysts' estimates of $41.4 billion. Meta expects to spend $64 billion to $72 billion this year, up from its prior outlook, due to tariffs imposed by the Trump administration and investments in artificial intelligence. Meta's advertising business, which makes up 98% of the company's revenue, is growing, and the company is investing heavily in AI development, including a new standalone AI app, to compete with rivals.
- Eli Lilly (LLY) dropped in the premarket after the drugmaker cut its adjusted earnings per share forecast for the full year. The company also reported first-quarter sales of its blockbuster weight-loss drug, Zepbound, that was in line with expectations. It also follows CVS' drug-benefits unit negotiated a deal to make Novo Nordisk A/S's Wegovy more widely available to its members, replacing Zepbound.
- Harley Davidson (HOG) shares are lower after pulling its 2025 financial outlook, citing the “tariff situation” and macroeconomic conditions. It also reported revenue for the first quarter that missed the average analyst estimate.

See omnystudio.com/listener for privacy information.

213 episodes

#Daily News #Business News #Business #News #iHeartPodcasts